HERON ELAINE J — SEC Form 4 filings
SEC reporting owner CIK 1235471. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-05-23 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 42,400 shares, $315,921 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: purchase of 2,400 shares @ $125.00 ($300,000) in PALVELLA THERAPEUTICS, INC., filed 2026-03-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PALVELLA THERAPEUTICS, INC. (PVLA) | Director | 4 | 1 leg · 2,400 sh · $300,000 | — | 3 |
| Vaxart, Inc. (VXRT) | Director | 4 | 2 legs · 40,000 sh · $15,921 | — | 6 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | Director | 2 | — | — | 4 |
Form 4 filings — HERON ELAINE J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | Vaxart, Inc. (VXRT) | Grant/award (A): 39,400 @ $0 · Grant/award (A): 78,700 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Purchase (P): 2,400 @ $125 | EDGAR |
| 2025-11-21 | 4 | Vaxart, Inc. (VXRT) | Purchase (P): 23,217 @ $0.39 · Purchase (P): 16,783 @ $0.41 | EDGAR |
| 2025-06-16 | 4 | Vaxart, Inc. (VXRT) | Grant/award (A): 16,000 @ $0 · Grant/award (A): 95,400 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/award (A): 12,350 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/award (A): 24,700 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Vaxart, Inc. (VXRT) | Grant/award (A): 16,000 @ $0 · Grant/award (A): 95,400 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Option exercise (M): 5,047 @ $63.10 · Tax withholding (F): 4,168 @ $76.41 · Option exercise (M): 5,047 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 4,720 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1235471 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →